Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | BrO3.K |
| Molecular Weight | 167.001 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[K+].[O-]Br(=O)=O
InChI
InChIKey=OCATYIAKPYKMPG-UHFFFAOYSA-M
InChI=1S/BrHO3.K/c2-1(3)4;/h(H,2,3,4);/q;+1/p-1
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | BrO3 |
| Molecular Weight | 127.902 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Altered hepatic mRNA expression of immune response-associated DNA damage in mice liver induced by potassium bromate: Protective role of vanillin. | 2016-12 |
|
| Protective effect of taurine against potassium bromate-induced hemoglobin oxidation, oxidative stress, and impairment of antioxidant defense system in blood. | 2016-03 |
|
| Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system. | 2016-02 |
|
| Epigenetic changes in p21 expression in renal cells after exposure to bromate. | 2014-10 |
|
| Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damage. | 2014-09-16 |
|
| ERK oscillation-dependent gene expression patterns and deregulation by stress response. | 2014-09-15 |
|
| Potassium bromate causes cell lysis and induces oxidative stress in human erythrocytes. | 2014-02 |
|
| Changes in mRNA and protein expression in the renal cortex of male and female F344 rats treated with bromate. | 2013-11 |
|
| Association of brominated proteins and changes in protein expression in the rat kidney with subcarcinogenic to carcinogenic doses of bromate. | 2013-10-15 |
|
| Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependent. | 2013-01-07 |
|
| Pro-oxidant induced DNA damage in human lymphoblastoid cells: homeostatic mechanisms of genotoxic tolerance. | 2012-08 |
|
| The ToxTracker assay: novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals. | 2012-01 |
|
| Possible involvement of oxidative stress in potassium bromate-induced genotoxicity in human HepG2 cells. | 2011-02-01 |
|
| Cellular and molecular mechanisms of bromate-induced cytotoxicity in human and rat kidney cells. | 2010-02-28 |
|
| Anomalous genotoxic responses induced in mouse lymphoma L5178Y cells by potassium bromate. | 2010-01-12 |
|
| Potassium bromate enhances N-ethyl-N-hydroxyethylnitrosamine-induced kidney carcinogenesis only at high doses in Wistar rats: indication of the existence of an enhancement threshold. | 2009-12 |
|
| DNA fragmentation and DNA repair synthesis induced in rat and human thyroid cells by chemicals carcinogenic to the rat thyroid. | 2006-10-30 |
|
| Oxidative DNA damage from potassium bromate exposure in Long-Evans rats is not enhanced by a mixture of drinking water disinfection by-products. | 2005-04-15 |
|
| Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumors. | 2002-12-10 |
|
| Requirement of glutathione and cysteine in guanine-specific oxidation of DNA by carcinogenic potassium bromate. | 2001-06 |
|
| The protective role of glutathione, cysteine and vitamin C against oxidative DNA damage induced in rat kidney by potassium bromate. | 1992-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:39:29 GMT 2025
by
admin
on
Mon Mar 31 18:39:29 GMT 2025
|
| Record UNII |
04MB35W6ZA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 172.730
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000053617
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
231-829-8
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
1253
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
34298
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | RxNorm | ||
|
04MB35W6ZA
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
POTASSIUM BROMATE
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
215200
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
7758-01-2
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
C019536
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
DTXSID6020195
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
38211
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | |||
|
m9008
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
23673461
Created by
admin on Mon Mar 31 18:39:29 GMT 2025 , Edited by admin on Mon Mar 31 18:39:29 GMT 2025
|
PRIMARY |